Cho-Chung YS - Search Results

1

CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth.

Cho-Chung YS, Park YG, Nesterova M, Lee YN, Cho YS. Cho-Chung YS, et al. Mol Cell Biochem. 2000 Sep;212(1-2):29-34. Mol Cell Biochem. 2000. PMID: 11108133 Review.

2

Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.

Cho-Chung YS, Nesterova M, Becker KG, Srivastava R, Park YG, Lee YN, Cho YS, Kim MK, Neary C, Cheadle C. Cho-Chung YS, et al. Ann N Y Acad Sci. 2002 Jun;968:22-36. doi: 10.1111/j.1749-6632.2002.tb04324.x. Ann N Y Acad Sci. 2002. PMID: 12119265 Review.

3

A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.

Cho YS, Kim MK, Cheadle C, Neary C, Park YG, Becker KG, Cho-Chung YS. Cho YS, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15626-31. doi: 10.1073/pnas.242617799. Epub 2002 Nov 18. Proc Natl Acad Sci U S A. 2002. PMID: 12438686 Free PMC article.

4

Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.

Nesterova MV, Cho-Chung YS. Nesterova MV, et al. Clin Cancer Res. 2004 Jul 1;10(13):4568-77. doi: 10.1158/1078-0432.CCR-03-0436. Clin Cancer Res. 2004. PMID: 15240549

5

Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth.

Park YG, Nesterova M, Agrawal S, Cho-Chung YS. Park YG, et al. J Biol Chem. 1999 Jan 15;274(3):1573-80. doi: 10.1074/jbc.274.3.1573. J Biol Chem. 1999. PMID: 9880535 Free article.

6

Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.

Kondrashin A, Nesterova M, Cho-Chung YS. Kondrashin A, et al. Biochemistry. 1999 Jan 5;38(1):172-9. doi: 10.1021/bi982090e. Biochemistry. 1999. PMID: 9890895

7

Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.

Cho YS, Park YG, Lee YN, Kim MK, Bates S, Tan L, Cho-Chung YS. Cho YS, et al. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):835-40. doi: 10.1073/pnas.97.2.835. Proc Natl Acad Sci U S A. 2000. PMID: 10639166 Free PMC article.

8

CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.

Lee YN, Park YG, Choi YH, Cho YS, Cho-Chung YS. Lee YN, et al. Biochemistry. 2000 Apr 25;39(16):4863-8. doi: 10.1021/bi992272o. Biochemistry. 2000. PMID: 10769144

9

Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.

Nesterova M, Cho-Chung YS. Nesterova M, et al. Antisense Nucleic Acid Drug Dev. 2000 Dec;10(6):423-33. doi: 10.1089/oli.1.2000.10.423. Antisense Nucleic Acid Drug Dev. 2000. PMID: 11198926

10

Oligonucleotides as transcription factor decoys.

Cho-Chung YS, Park YG, Lee YN. Cho-Chung YS, et al. Curr Opin Mol Ther. 1999 Jun;1(3):386-92. Curr Opin Mol Ther. 1999. PMID: 11713803 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters